Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2025-12-31 @ 11:03 AM
Study NCT ID:
NCT04255433
Status:
COMPLETED
Last Update Posted:
2025-08-24
First Post:
2020-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-29
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-12
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-03
First Submit QC Date:
None
Study First Post Date:
2020-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-22
Last Update Post Date:
2025-08-24
Last Update Post Date Type:
ACTUAL